Diabetologia

, Volume 57, Issue 5, pp 1084–1085

Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed? Reply to Lewis G and Maxwell AP [letter]

  • Peter W. G. Tennant
  • Svetlana V. Glinianaia
  • Rudy W. Bilous
  • Judith Rankin
  • Ruth Bell
Letter

DOI: 10.1007/s00125-014-3191-2

Cite this article as:
Tennant, P.W.G., Glinianaia, S.V., Bilous, R.W. et al. Diabetologia (2014) 57: 1084. doi:10.1007/s00125-014-3191-2

Keywords

ACE inhibitorsAngiotensin II receptor antagonistsHbA1cHypertensionNephropathyPregnancy

Abbreviations

ACEI

ACE inhibitor

ARB

Angiotensin II receptor blocker

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Peter W. G. Tennant
    • 1
  • Svetlana V. Glinianaia
    • 1
  • Rudy W. Bilous
    • 2
    • 3
  • Judith Rankin
    • 1
    • 4
  • Ruth Bell
    • 1
    • 4
  1. 1.Institute of Health & SocietyNewcastle UniversityNewcastle upon TyneUK
  2. 2.Institute of Cellular MedicineNewcastle UniversityNewcastle upon TyneUK
  3. 3.James Cook University HospitalSouth Tees NHS TrustMiddlesbroughUK
  4. 4.Regional Maternity Survey OfficePublic Health EnglandNewcastle upon TyneUK